Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

beta-Thalassemia 1Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Seizures After Brain Tumor Surgery 1Neurofibromatosis 1 1Neuroblastoma 1Neoplasm, Residual 1Necrosis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Influenza, Human 1Hematologic Neoplasms 1Chromosome Aberrations 1Chromosome 7, monosomy 1Brain Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 15fludarabine 12Mycophenolic Acid 10Standard of Care 9Whole-Body Irradiation 7Tacrolimus 7venetoclax 6Specimen Handling 6Sirolimus 6Practice Guidelines as Topic 6trametinib 5Melphalan 5fludarabine phosphate 4Mesna 4Magnetic Resonance Spectroscopy 4Filgrastim 4Biopsy 4Behavior Therapy 4Azacitidine 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3GSK2636771 3Educational Status 3Crizotinib 3Busulfan 3thymoglobulin 2talquetamab 2ruxolitinib 2palbociclib 2osimertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Levetiracetam × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡